14993

    0

    SOTAC

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SOTAC PHARMACEUTICALS LTD Share Price Today

    SOTAC PHARMACEUTICALS LTD is currently trading at ₹90.4, up by ₹0.0 from the previous close. The stock touched an intraday high of ₹90.40 and a low of ₹90.40 during the latest trading session. Over the past one year, SOTAC PHARMACEUTICALS LTD has delivered a loss of 27.06%, while the stock has declined 13.9% in the last one month.

    SOTAC PHARMACEUTICALS LTD performance

    Today’s low Today’s high
    ₹ 90.40 ₹ 90.40
    ₹ 90.40
    52 week low 52 week high
    ₹ 90.40 ₹ 139.65
    ₹ 90.40
    Open Price ₹ 90.40
    Prev. Close ₹ 90.40
    Volume (Shares) 1200.00
    Total traded value ₹ 1.08
    Upper Circuit ₹ 94.90
    Lower Circuit ₹ 85.90
    info

    Investment Returns

    Over 1 Month -13.90% Over 3 Months -18.66% Over 6 Months -19.92% Over 1 Year -27.06%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SOTAC PHARMACEUTICALS LTD fundamentals


    • Market cap (Cr) 99.90
    • P/E Ratio (TTM) 20.31
    • Beta -0.04
    • Book Value / share 52.32
    • Return on equity 9.42%
    • EPS (TTM) 4.45
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.86
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    SOTAC PHARMACEUTICALS LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars SEP 2024 (Values in Cr)
    Revenue 17.60
    Operating Expense 0.00
    Net Profit 0.86
    Net Profit Margin (%) 4.88
    Earnings Per Share (EPS) 0.78
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars JUN 2024 (Values in Cr)
    Revenue 13.01
    Operating Expense 11.77
    Net Profit 1.25
    Net Profit Margin (%) 9.60
    Earnings Per Share (EPS) 1.13
    EBITDA 2.53
    Effective Tax Rate (%) 25.14
    Particulars MAR 2024 (Values in Cr)
    Revenue 16.31
    Operating Expense 14.98
    Net Profit 1.38
    Net Profit Margin (%) 8.46
    Earnings Per Share (EPS) 1.25
    EBITDA 2.84
    Effective Tax Rate (%) 25.80
    Particulars DEC 2023 (Values in Cr)
    Revenue 17.68
    Operating Expense 15.66
    Net Profit 1.49
    Net Profit Margin (%) 8.42
    Earnings Per Share (EPS) 2.65
    EBITDA 2.97
    Effective Tax Rate (%) 27.66
    Particulars SEP 2023 (Values in Cr)
    Revenue 14.20
    Operating Expense 12.34
    Net Profit 1.67
    Net Profit Margin (%) 11.76
    Earnings Per Share (EPS) 1.52
    EBITDA 2.96
    Effective Tax Rate (%) 22.32
    Particulars MAR 2026 (Values in Cr)
    Revenue 71.88
    Operating Expense 67.05
    Net Profit 4.92
    Net Profit Margin (%) 6.84
    Earnings Per Share (EPS) 4.45
    EBITDA 11.21
    Effective Tax Rate (%) 29.04
    Particulars MAR 2025 (Values in Cr)
    Revenue 62.38
    Operating Expense 58.35
    Net Profit 4.77
    Net Profit Margin (%) 7.64
    Earnings Per Share (EPS) 4.32
    EBITDA 10.05
    Effective Tax Rate (%) 25.58
    Particulars MAR 2024 (Values in Cr)
    Revenue 67.11
    Operating Expense 60.43
    Net Profit 5.75
    Net Profit Margin (%) 8.56
    Earnings Per Share (EPS) 5.24
    EBITDA 11.28
    Effective Tax Rate (%) 25.90
    Particulars MAR 2023 (Values in Cr)
    Revenue 57.98
    Operating Expense 52.26
    Net Profit 4.50
    Net Profit Margin (%) 7.76
    Earnings Per Share (EPS) 5.58
    EBITDA 8.45
    Effective Tax Rate (%) 24.66
    Particulars MAR 2022 (Values in Cr)
    Revenue 73.15
    Operating Expense 68.67
    Net Profit 3.30
    Net Profit Margin (%) 4.51
    Earnings Per Share (EPS) 14.33
    EBITDA 6.37
    Effective Tax Rate (%) 29.63
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 48.19
    ROE % 18.84
    ROCE % 16.37
    Total Debt to Total Equity 0.70
    EBITDA Margin 18.07
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 40.96
    ROE % 11.06
    ROCE % 10.19
    Total Debt to Total Equity 0.72
    EBITDA Margin 8.48
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 12.41
    ROE % 10.07
    ROCE % 12.96
    Total Debt to Total Equity 1.13
    EBITDA Margin 9.89
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 10.84
    ROE % -85.41
    ROCE % -5.69
    Total Debt to Total Equity 5.51
    EBITDA Margin 3.21
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 13.29
    ROE % 2.61
    ROCE % 3.90
    Total Debt to Total Equity 4.39
    EBITDA Margin 7.15
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 47.99
    ROE % 9.42
    ROCE % 11.41
    Total Debt to Total Equity 0.31
    EBITDA Margin 16.13
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 43.69
    ROE % 16.60
    ROCE % 19.24
    Total Debt to Total Equity 0.32
    EBITDA Margin 16.82
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 14.31
    ROE % 32.04
    ROCE % 29.73
    Total Debt to Total Equity 0.64
    EBITDA Margin 14.64
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 30.87
    ROE % 76.91
    ROCE % 54.73
    Total Debt to Total Equity 1.18
    EBITDA Margin 11.25
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 20.90
    ROE % 34.78
    ROCE % 18.64
    Total Debt to Total Equity 1.64
    EBITDA Margin 7.39
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.56
    Total Assets 124.32
    Total Liabilities 124.32
    Total Equity 58.42
    Share Outstanding 1
    Price to Book Ratio 2.47
    Return on Assets (%) 6.45
    Return on Capital (%) 7.86
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 3.41
    Total Assets 105.32
    Total Liabilities 105.32
    Total Equity 49.32
    Share Outstanding 1
    Price to Book Ratio 2.77
    Return on Assets (%) 4.06
    Return on Capital (%) 5.77
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 9.68
    Total Assets 73.63
    Total Liabilities 73.63
    Total Equity 19.68
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.91
    Return on Capital (%) 6.9
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.26
    Total Assets 34.69
    Total Liabilities 34.69
    Total Equity 2.56
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -6.81
    Return on Capital (%) -12.01
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 0.42
    Total Assets 30.38
    Total Liabilities 30.38
    Total Equity 4.71
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.28
    Return on Capital (%) 0.48
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.44
    Total Assets 85.29
    Total Liabilities 85.29
    Total Equity 53.02
    Share Outstanding 1
    Price to Book Ratio 2.47
    Return on Assets (%) 5.59
    Return on Capital (%) 6.52
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.64
    Total Assets 76.08
    Total Liabilities 76.08
    Total Equity 48.27
    Share Outstanding 1
    Price to Book Ratio 2.77
    Return on Assets (%) 7.55
    Return on Capital (%) 9.67
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 9.59
    Total Assets 54.78
    Total Liabilities 54.78
    Total Equity 20.99
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 8.20
    Return on Capital (%) 14.2
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 36.29
    Total Liabilities 36.29
    Total Equity 7.09
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 9.07
    Return on Capital (%) 22.75
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 22.49
    Total Liabilities 22.49
    Total Equity 4.80
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.59
    Return on Capital (%) 12.91
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.11
    Cash from Operations -3.52
    Cash from Investing -13.61
    Cash from Financing 16.09
    Net change in Cash -1.85
    Free Cash Flow 13.48
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.96
    Cash from Operations -14.38
    Cash from Investing -19.67
    Cash from Financing 29.49
    Net change in Cash -6.26
    Free Cash Flow -1.67
    Particulars MAR 2023 (Values in Cr)
    Net Income 3.92
    Cash from Operations 9.82
    Cash from Investing -11.67
    Cash from Financing 13.13
    Net change in Cash 9.60
    Free Cash Flow 18.82
    Particulars MAR 2021 (Values in Cr)
    Net Income -2.05
    Cash from Operations 0.11
    Cash from Investing -3.23
    Cash from Financing 3.37
    Net change in Cash -0.15
    Free Cash Flow 3.27
    Particulars MAR 2020 (Values in Cr)
    Net Income 0.35
    Cash from Operations 0.30
    Cash from Investing -11.74
    Cash from Financing 11.39
    Net change in Cash -0.29
    Free Cash Flow 10.10
    Particulars MAR 2025 (Values in Cr)
    Net Income 6.41
    Cash from Operations -5.27
    Cash from Investing -1.89
    Cash from Financing 7.77
    Net change in Cash -0.19
    Free Cash Flow -3.80
    Particulars MAR 2024 (Values in Cr)
    Net Income 7.75
    Cash from Operations -18.05
    Cash from Investing -12.52
    Cash from Financing 23.31
    Net change in Cash -8.95
    Free Cash Flow -11.95
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.96
    Cash from Operations 10.22
    Cash from Investing -10.93
    Cash from Financing 11.96
    Net change in Cash 9.57
    Free Cash Flow 17.26
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.68
    Cash from Operations 5.00
    Cash from Investing -3.27
    Cash from Financing -0.30
    Net change in Cash 0.00
    Free Cash Flow 8.51
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.00
    Cash from Operations 0.74
    Cash from Investing -1.06
    Cash from Financing -1.17
    Net change in Cash -0.01
    Free Cash Flow 1.87
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 12.82 1.49 236.72 23.12 38.85
    BLISS GVS PHARMA LTD. 458.05 36.82 4.07 4857.91 118.35 552.90
    CIPLA LTD 1473.45 33.26 3.45 119031.97 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 451.45 21.12 3.26 1328.66 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 21.60 3.97 236.72 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 516.80 23.16 4.03 1494.10 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8179.35 106.89 23.42 20448.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 458.05 49.52 4.20 4857.91 118.35 552.90

    SOTAC PHARMACEUTICALS LTD shareholding pattern

    Holding
    10.36%
    72.85%
    16.78%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    SOTAC PHARMACEUTICALS LTD Technicals Summary

    90.40 0.00 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 96.50
    • 26 Days 104.80
    • 10 Days 100.00
    • 50 Days 109.00
    • 12 Days 100.90
    • 100 Days 114.00
    • 20 Days 103.50
    • 200 Days 118.60
    90.40 PIVOT
    First Support 90.40 First Resistance 90.40 Second Support 90.40 Second Resistance 90.40 Third Support 90.40 Third Resistance 90.40
    RSI 25.57 ADX 22.09 MACD -3.89 Williams % R -100.00 Commodity Channel Index (CCI) -240.90
    Date 2026-07-29 Week 1200.00 Same Day 1200.00 Month 25886.00
    1 Year -0.05 3 Year 0.58
    Over 1 Month
    -13.90% down
    Over 1 Year
    -27.06% down
    Over 3 Months
    -18.66% down
    Over 3 Years
    -8.36% down
    Over 6 Months
    -19.92% down
    Over 5 Years
    0.00% down

    SOTAC PHARMACEUTICALS LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2025 0.1 Final 19 Sep 2025 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sotac Pharmaceuticals Ltd?

    Answer Field

    Sotac Pharmaceuticals Ltd share price is for NSE ₹ 90.40 & for BSE ₹ 0.00 as on Jul 29 2026 03:07 PM.

    What is the Market Cap of Sotac Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Sotac Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 29 2026 03:07 PM.

    What is the 52 Week High and Low of Sotac Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Sotac Pharmaceuticals Ltd for NSE is ₹ 139.65 and ₹ 90.40 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Sotac Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -27.06%.

    What is the P/E Ratio of Sotac Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 29 2026 03:07 PM the price-to-earnings (PE) ratio for Sotac Pharmaceuticals Ltd share is 20.31.

    What is the PB ratio of Sotac Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 29 2026 03:07 PM, the price-to-book (PB) ratio for Sotac Pharmaceuticals Ltd share is 52.32.

    How to Buy Sotac Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Sotac Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sotac Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sotac Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Sotac Pharmaceuticals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |